Elixir Medical Corporation - Product Pipeline Analysis, 2016 Update

Date: March 9, 2016
Pages: 27
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E796DAC84ABEN
Leaflet:

Download PDF Leaflet

Elixir Medical Corporation - Product Pipeline Analysis, 2016 Update
Summary

Elixir Medical Corporation (Elixir Medical) is a medical device company that manufactures and distributes drug eluting stent systems for the healthcare sector. The company’s products include next-generation drug-eluting stent systems, bioresorbable scaffolds, cardiology devices, eluting coronary stent systems, eluting bioresorbable coronary scaffold systems, and coronary stent systems. Its other products comprise pipeline products, small vessel stent systems, fully absorbable drug eluting scaffold stent systems, advanced pharmaceutical products, and others. Elixir Medical offers services such as research and development, polymer coating technology services, bioabsorbal material solutions, innovating vascular restoration, clinical trials, clinical studies, drug delivery services, and others. The company operates in the US and Ireland. Elixir Medical is headquartered in Sunnyvale, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Elixir Medical Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • Elixir Medical Corporation Company Snapshot
    Elixir Medical Corporation Company Overview
    Key Information
    Elixir Medical Corporation Pipeline Products and Clinical Trials Overview
    Elixir Medical Corporation - Major Products and Services
    Elixir Medical Corporation Pipeline Products by Development Stage
    Elixir Medical Corporation Pipeline Products Overview
    DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System
    DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System Product Overview
    DESyne Nx Novolimus Eluting Coronary Stent System
    DESyne Nx Novolimus Eluting Coronary Stent System Product Overview
    Myolimus Eluting Coronary Stent - Durable Polymer
    Myolimus Eluting Coronary Stent - Durable Polymer Product Overview
    Peripheral Vascular Resorbable Scaffold
    Peripheral Vascular Resorbable Scaffold Product Overview
    Elixir Medical Corporation - Key Competitors
    Elixir Medical Corporation - Key Employees
    Elixir Medical Corporation - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    Elixir Medical Corporation, Recent Developments
    Oct 15, 2015: Elixir Medical Announces Excellent, 3-year Clinical and Imaging Results for the CE-Marked Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    Oct 13, 2015: Elixir Medical Announces Successful Live Case Transmission of DESolve Cx at TCT 2015
    Aug 18, 2015: Elixir Medical Receives 2015 Innovator of the Year Award from EK-UNICO
    May 20, 2015: Elixir Medical Announces Excellent, 3-year Imaging Results for the CE-Marked Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    May 13, 2015: Elixir Medical to Showcase Results for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold Systems at EuroPCR 2015
    Sep 08, 2014: Elixir Medical Announces Schedule of Programs for TCT 2014
    May 23, 2014: Elixir Medical Announces Outstanding Long-Term Clinical Results at EuroPCR for World’s Broadest Portfolio of Three CE Mark-Approved Novolimus Eluting Coronary Intervention Systems
    May 23, 2014: Elixir Medical Announces Results for CE mark-approved DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System at EuroPCR
    May 23, 2014: Elixir Medical Announces Clinical Trial Results of DESyne BD Novolimus Eluting Coronary Stent System at EuroPCR
    May 23, 2014: Elixir Medical Announces Outstanding Long-term Clinical Results of DESyne Novolimus Eluting Coronary Stent System at EuroPCR
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Elixir Medical Corporation, Key Facts
    Elixir Medical Corporation Pipeline Products and Clinical Trials Overview
    Elixir Medical Corporation Pipeline Products by Equipment Type
    Elixir Medical Corporation Pipeline Products by Indication
    Elixir Medical Corporation, Major Products and Services
    Elixir Medical Corporation Number of Pipeline Products by Development Stage
    Elixir Medical Corporation Pipeline Products Summary by Development Stage
    DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Status
    DESolve Myolimus Eluting Bioresorbable Coronary Scaffold System - Product Description
    DESyne Nx Novolimus Eluting Coronary Stent System - Product Status
    DESyne Nx Novolimus Eluting Coronary Stent System - Product Description
    Myolimus Eluting Coronary Stent - Durable Polymer - Product Status
    Myolimus Eluting Coronary Stent - Durable Polymer - Product Description
    Peripheral Vascular Resorbable Scaffold - Product Status
    Peripheral Vascular Resorbable Scaffold - Product Description
    Elixir Medical Corporation, Key Employees
    Elixir Medical Corporation, Other Locations

    LIST OF FIGURES

    Elixir Medical Corporation Pipeline Products by Equipment Type
    Elixir Medical Corporation Pipeline Products by Development Stage
    Skip to top


    Ask Your Question

    Elixir Medical Corporation - Product Pipeline Analysis, 2016 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: